- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Nov 26, 1999
Highlights
- Market Cap
- $5.90B
- Enterprise Value
- $78.47B
- EPS (TTM)
- $0.73
- PE Ratio
- 22.09
- PEG Ratio
- 0.17
- Total Revenue (TTM)
- $24.01B
- Gross Profit (TTM)
- $6.49B
- EBITDA (TTM)
- $10.19B
- Year Range
- $15.10 - $17.82
- ROA (TTM)
- 0.27%
- ROE (TTM)
- 6.30%
- Avg. Volume (1M)
- 15K
- Avg. Volume Value (1M)
- $248.81K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
BIPH Performance Chart
Biophan Technologies, Inc (BIPH) is up 3.1% since the beginning of the year. At $16 per share, BIPH is trading 9.3% below its 52-week high of $18. Investors who bought $1,000 worth of BIPH shares 5 years ago would now be looking at an investment worth $878.
Loading charts...
Compare this symbol against anything
Returns By Period
Biophan Technologies, Inc (BIPH) has returned 3.10% so far this year and 3.68% over the past 12 months.
Biophan Technologies, Inc
- 1D
- 0.75%
- 1M
- 2.02%
- 6M
- -0.09%
- YTD
- 3.10%
- 1Y
- 3.68%
- 3Y*
- 4.18%
- 5Y*
- -2.57%
- 10Y*
- —
- ALL TIME*
- -1.82%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
BIPH Monthly Returns History
Based on dividend-adjusted daily data since May 26, 2021, BIPH's average daily return is 0.00%, while the average monthly return is +0.06%. At this rate, an investment would double in approximately 96.3 years.
Historically, 46% of months were positive and 54% were negative. The best month was Jan 2023 with a return of +30.9%, while the worst month was Apr 2022 at -11.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 4 months.
On a daily basis, BIPH closed higher 49% of trading days. The best single day was Mar 16, 2023 with a return of +7.8%, while the worst single day was Feb 21, 2023 at -6.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.19% | -2.20% | -6.37% | 8.87% | 0.61% | -4.95% | 4.80% | 3.10% | |||||
| 2025 | 10.50% | -0.60% | -8.34% | -2.12% | -0.00% | 0.26% | 6.81% | 0.06% | 1.55% | -0.06% | -0.41% | -1.38% | 5.24% |
| 2024 | 5.18% | 9.63% | -3.31% | -7.44% | 2.41% | 2.94% | -2.95% | 6.36% | 7.39% | 0.73% | -6.09% | -6.85% | 6.28% |
| 2023 | 30.86% | -5.16% | -2.63% | -5.42% | 3.13% | 5.94% | -3.40% | -3.80% | -1.27% | -8.39% | 6.41% | 5.12% | 17.39% |
| 2022 | -5.45% | -8.49% | 2.24% | -11.27% | 5.30% | -9.25% | 14.07% | -9.69% | -10.06% | -4.38% | 0.44% | -1.90% | -34.53% |
| 2021 | 0.75% | -0.16% | 2.95% | -0.08% | 1.27% | -0.69% | -2.90% | 1.52% | 2.59% |
Benchmark Metrics
Biophan Technologies, Inc has an annualized alpha of -4.05%, beta of 0.41, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since May 26, 2021.
- This stock participated in 124.23% of S&P 500 Index downside but only 68.57% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.41 may look defensive, but with R2 of 0.08 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -4.05%
- Beta
- 0.41
- R²
- 0.08
- Upside Capture
- 68.57%
- Downside Capture
- 124.23%
Return for Risk
Risk / Return Rank
BIPH ranks 49 for risk / return — above 49% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Biophan Technologies, Inc (BIPH) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIPH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.21 | ||
| Sortino ratioReturn per unit of downside risk | -1.61 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.25 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | 0.25 | 2.00 | -1.75 |
| Martin ratioReturn relative to average drawdown | 0.77 | 8.49 | -7.72 |
Dividends
Dividend History
Biophan Technologies, Inc provided a 7.76% dividend yield over the last twelve months, with an annual payout of $1.25 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Dividend | $1.25 | $1.25 | $1.25 | $1.25 | $1.25 | $0.75 |
Dividend yield | 7.76% | 7.69% | 7.50% | 7.46% | 8.10% | 3.00% |
Monthly Dividends
The table displays the monthly dividend distributions for Biophan Technologies, Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | $0.00 | $0.63 | |||||
| 2025 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.32 | $1.25 |
| 2024 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | $1.25 |
| 2023 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | $1.25 |
| 2022 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.31 | $1.25 |
| 2021 | $0.44 | $0.00 | $0.00 | $0.32 | $0.75 |
Dividend Yield & Payout
Dividend Yield
Biophan Technologies, Inc has a dividend yield of 7.76%, which means its dividend payment is significantly above the market average.
Payout Ratio
Biophan Technologies, Inc has a payout ratio of 249.85%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Biophan Technologies, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Biophan Technologies, Inc was 38.18%, occurring on Oct 21, 2022. The portfolio has not yet recovered.
The current Biophan Technologies, Inc drawdown is 14.42%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-38.18%Oct 2022 | 1y 28d | — | 4y 10moSep 2021 - now | Bear market2022 |
-2.36%Aug 2021 | 4d | 22d | 26dAug 2021 - Sep 2021 | — |
-1.02%Jun 2021 | 24d | 11d | 1mo 5dMay 2021 - Jul 2021 | — |
-0.85%Jul 2021 | 4d | 2d | 6dJul 2021 - Jul 2021 | — |
-0.81%Jul 2021 | 4d | 3d | 7dJul 2021 - Jul 2021 | — |
Drawdown Indicators
| BIPH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.18% | -56.78% | +18.60% |
Max Drawdown (1Y)Largest decline over 1 year | -11.16% | -9.10% | -2.06% |
Max Drawdown (3Y)Largest decline over 3 years | -22.01% | -18.90% | -3.11% |
Max Drawdown (5Y)Largest decline over 5 years | -38.18% | -25.43% | -12.75% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -14.42% | -1.58% | -12.84% |
Average DrawdownAverage peak-to-trough decline | -18.25% | -10.70% | -7.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.67% | 2.14% | +1.53% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Biophan Technologies, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Biophan Technologies, Inc is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for BIPH, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, BIPH has a P/E ratio of 22.1. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for BIPH compared to other companies in the Medical Instruments & Supplies industry. BIPH currently has a PEG ratio of 0.2. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for BIPH relative to other companies in the Medical Instruments & Supplies industry. Currently, BIPH has a P/S ratio of 0.3. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for BIPH in comparison with other companies in the Medical Instruments & Supplies industry. Currently, BIPH has a P/B value of 1.6. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with BIPH
Add Biophan Technologies, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with BIPH